Prion-like Domains in Eukaryotic Viruses
April 1, 2026: Lawsuits Involving Ozempic & Other GLP-1s Climb to Over 3,500 Ozempics manufacturer, Novo Nordisk, and one other GLP-1 company are facing about 3,546 lawsuits in an active, federally consolidated MDL filed by former patients and their loved ones
Nakano M, Osada K, Misonoo A, Fujiwara K, Takahashi M, Ogawa Y, et al
Accordingly, people with type 2 diabetes, cardiovascular disease, heart failure, or chronic kidney disease should be treated appropriately with an SGLT-2 inhibitor or GLP-1RA, even because more adults with type 2 diabetes in the US have suboptimal glycemic control now compared to 10 years ago, associated with a resurgence in vascular diabetic complications [32]
This page covers research peptides sold for laboratory use
(Bateman et al., 29423816) N-acetylcysteine can be used in patients with a history of anaphylactoid reactions (although it may be wise to initiate the infusion at a lower dose and pre-treat with antihistamines)